NSW backs Agscent with AUD $1.25M for one-minute cattle breath test
NSW grants Agscent AUD $1.25M toward a AUD $1.5M project: a handheld cattle breath test using nanosensors and AI to detect bovine respiratory disease in under a minute.

Why it matters
- Agscent received AUD $1.25 million from the NSW Government toward a AUD $1.5 million project via the Emerging Technology Commercialisation Fund.
- The breath test is designed to detect bovine respiratory disease in under a minute, distinguishing bacterial from viral infection.
- BRD costs Australian producers an estimated AUD $60–100 million per year.
- The project will build 10 production prototypes and run field trials, targeting over 95% sensitivity and over 90% specificity.
- Funding runs over 20 months, with about 80% spent in NSW and three specialist roles created.
Agscent has secured AUD $1.25 million from the NSW Government to advance a handheld cattle breath test that returns a bovine respiratory disease result in less than a minute. The grant supports a AUD $1.5 million commercialisation project run through the Emerging Technology Commercialisation Fund, with the money spent over 20 months.
The NSW agricultural technology company is building a diagnostic system that analyses a single breath sample from a cow in the cattle yards, not in a laboratory. The test aims to detect bovine respiratory disease, known as BRD, before visible symptoms appear, and to distinguish between bacterial and viral infection so producers can choose the right treatment.
Why the disease matters
BRD is a major cost for Australia's feedlot sector. The source estimates put losses at between AUD $60 million and AUD $100 million a year, spread across animal deaths, lower productivity and treatment expenses. That scale makes early, accurate detection a direct financial question for producers, not just a welfare one.
Current screening methods leave a gap. Producers often rely on observing changes in behaviour, breathing or appetite — signs that appear after an infection has already taken hold. Where laboratory PCR testing is used, samples must be sent away, and results can take 24 to 48 hours to come back. In a feedlot environment, that delay affects both containment and treatment decisions.
How the breath test works
Agscent's system combines a proprietary breath sampler with nanosensors that detect volatile organic compounds in exhaled breath. Artificial intelligence interprets the chemical signatures linked to disease and classifies them.
The design target is use during routine cattle handling. A producer would sample an animal's breath in the yards and receive a result in under a minute, on the spot, according to the company's stated goals.
The work builds on research conducted with the NSW Department of Primary Industries at the Elizabeth Macarthur Agricultural Institute. Agscent said that research identified breath-based markers associated with key pathogens involved in BRD — the scientific foundation the commercialisation project now aims to harden.
Agscent also said it has adapted sensor technology originally developed for NASA applications, pairing it with its own breath-sampling hardware and AI tools built for livestock diagnostics.
What the AUD $1.5 million project delivers
Under the commercialisation programme, Agscent plans concrete outputs:
- 10 production-representative prototypes manufactured during the project.
- Field trials at multiple feedlot and dairy properties across New South Wales.
- Further development of the AI diagnostic system, with performance targets of more than 95 per cent sensitivity and more than 90 per cent specificity.
Those two targets define commercial viability: sensitivity above 95 per cent means the test catches the large majority of true infections, while specificity above 90 per cent limits false positives that would trigger unnecessary treatment.
The funding also carries an economic condition for the state. About 80 per cent of the spend is expected to occur in New South Wales, and the project is expected to create three specialist science and technology roles there.
What the founder says
Dr Bronwyn Darlington, Founder and Managing Director of Agscent, framed the test around the timing problem producers face: by the time symptoms show, damage is done.
"By the time a cow looks sick, the infection may already have spread and caused damage to its lungs," Darlington said.
"Farmers are often making treatment decisions without knowing exactly what they're dealing with. We've identified molecules in an animal's breath that can indicate whether it has a bacterial or viral infection before visible symptoms appear.
"Our goal is to give farmers that information in less than a minute, right there in the cattle yards, so they can identify affected animals earlier and make better decisions about treatment."
Darlington said the company has already demonstrated it can detect disease-related signals in cattle breath. The remaining question is consistency at commercial scale.
"We've already demonstrated that we can identify disease-related signals in cattle breath. The next challenge is proving the technology works consistently in the real world, across different animals, farms and conditions," she said.
"This funding allows us to take that next step, working directly with producers to develop a practical, affordable diagnostic tool that can become part of everyday livestock management. It also means we can advance the technology here in NSW, building on Australian research and creating the foundations for local manufacturing and international growth."
Beyond the Australian feedlot
The NSW project is not Agscent's only commercial track. The company is also running separate trials with Dairy Farmers of America as it examines overseas commercial opportunities — a signal that the technology is being positioned for export markets, not only the domestic feedlot sector.
The BRD test is one application of a broader platform. Darlington said the underlying method — reading chemical signals in breath — could identify other diseases beyond respiratory illness.
"Every breath an animal takes contains information about what's happening inside its body," Darlington said.
"We're reading that information and turning it into something farmers can use. Respiratory disease is an important application because the costs to producers are so high. But the same technology has the potential to help identify other diseases and improve how we monitor animal health more broadly."
The road ahead
The next 20 months determine whether a laboratory-proven breath diagnostic survives contact with real feedlot conditions. The field trials across New South Wales feedlot and dairy properties will test whether the AI system holds its sensitivity and specificity targets across different animals, farms and conditions — the exact variables Darlington identified as the outstanding challenge.
Success would put a sub-minute, yards-side diagnostic in producers' hands against a disease that costs the sector up to AUD $100 million annually, and would establish the NSW manufacturing base the company says it wants before pursuing international growth.
Source: itbrief.com.au
More from Rebecca Stone
Show full bio
Correspondent covering companies, deals and strategy in artificial intelligence and machine learning at AI In Context.
754 articles
Related articles
- Healthleap lands $38M to flag at-risk hospital patients with AI
- Anthropic brings in METR and SecureBio for outside risk assessments
- China Clears Harbour BioMed's AI-Designed Obesity Antibody LET003 for Human Trials
- Australia 'sleepwalking into another robodebt' over government AI use
- Isomorphic Labs Raises $5B as AI Drug Design Faces Trial Test